Tyler W
GLP-1 receptor agonists, or glucagon-like peptide-1 receptor agonists, were first developed to help people with type 2 diabetes manage their blood sugar levels
2024 Nov 10;43(11):114915
Your healthcare provider will tailor the dosage and frequency of semaglutide GLP-1 based on your individual needs, health profile, and progress
Secher A, Jelsing J, Baquero AF, Hecksher-Sorensen J, Cowley MA, Dalboge LS, Hansen G, Grove KL, Pyke C, Raun K, Schaffer L, Tang-Christensen M, Verma S, Witgen BM, Vrang N, and Bjerre Knudsen L
The decision to switch should be made in consultation with your doctor after considering various factors, such as your overall health and response to treatment